Scientists Discover How Retinal Cones Develop
Researchers find that thyroid hormones and retinoic acid govern the formation of crucial light-sensitive cones in the retina.
Updated on Oct. 31, 2026 in Nutrition
Live Poll
Do you believe scientists will successfully develop vision-restoration treatments for eye diseases in your lifetime?
Scientists at Johns Hopkins University have identified how retinoic acid and thyroid hormones regulate the development of light-sensitive cones in the human retina. The findings provide a new understanding of how the foveola forms the specialized cells essential for central vision.
Why it matters
Understanding these developmental signals could pave the way for producing photoreceptors to treat conditions like macular degeneration and glaucoma. This discovery challenges existing theories that suggested blue-sensitive cones simply migrate out of the foveola as the eye matures.
The foveola is estimated to contribute to 50 percent of human visual perception. Researchers observed these developmental processes in miniature retinal organoids over several months.
The players
Johns Hopkins University
This private research university in Baltimore is a world leader in medical research and the institution where this study was conducted.
The details
Researchers found that retinoic acid limits the formation of blue-sensitive cones in the central retina, while thyroid hormones encourage these cells to become red- or green-sensitive. By observing retinal organoids, the team debunked the theory that blue-sensitive cones migrate out of the foveola, proving instead that they transform in place.
Timeline
Blue-sensitive cones appear in the foveola during the 10th to 12th weeks of fetal development.
By the 14th week of fetal development, some blue-sensitive cones have developed into red- and green-sensitive cones.
The Big Picture
This study contradicts the historical migration theory of retinal development by proving cone transformation happens in place. The discovery shifts the scientific paradigm toward understanding localized chemical signaling as the primary driver of central vision specialization.
While this research offers promise for future treatments of macular degeneration, current common practices like taking vitamin A supplements do not improve adult vision. The findings instead prioritize future clinical pathways for transplanting specialized photoreceptors into damaged retinas.
The takeaway
These findings offer a blueprint for future regenerative medicine rather than immediate dietary interventions. Patients should focus on proven medical guidance for vision health while scientists work to apply these cellular insights to clinical treatments.
Further reading
Explore the latest Nutrition updates on how internal chemistry influences physical health and development.
Source note: This article includes information reported by Bangladeshpost.
Live Poll
Do you believe scientists will successfully develop vision-restoration treatments for eye diseases in your lifetime?
